Edwards Lifesciences, Inc. EW presented results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards ...
Edwards Lifesciences shared its outlook for 2023 at its investor day, and considering our projections for the various product lines and earnings remain bounded by management’s estimates, we’re leaving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback